86.90.E - Other human health activities notelsewhere classified
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.D - Paramedical activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | 0,5 | 0,7 | 31 |
Gross profit (loss) | 0,2 | 0,5 | 0,7 | 32,2 |
EBITDA | 0,2 | 0,5 | 0,7 | 30,9 |
Short time liabilities | 0,3 | 0,3 | 0,5 | 77,6 |
Other operating costs | 0 | 0 | 0 | 144,3 |
Equity capital | 0,8 | 0,8 | 0,9 | 11,8 |
Operating profit (EBIT) | 0,2 | 0,5 | 0,7 | 31,1 |
Assets | 1 | 1,1 | 1,4 | 28,3 |
Net profit (loss) | 0,2 | 0,5 | 0,7 | 32 |
Cash | 0,4 | 0,8 | 1,1 | 31,1 |
Liabilities and provisions for liabilities | 0,3 | 0,3 | 0,5 | 77,6 |
Net income from sale | 3,2 | 3,7 | 4,7 | 27,5 |
Working assets | 1 | 1,1 | 1,4 | 29,5 |
Other income costs | 0,1 | 0 | 0 | 1374,5 |
Depreciation | 0 | 0 | 0 | 19,9 |
% | % | % | p.p. | |
Profitability of capital | 23,2 | 59,2 | 69,9 | 10,7 |
Equity capital to total assets | 73,4 | 74,9 | 65,3 | -9,6 |
Gross profit margin | 5,7 | 14,7 | 15,3 | 0,6 |
EBITDA Margin | 7,1 | 14,5 | 14,8 | 0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 30 | 28 | 38 | 10 |
Current financial liquidity indicator | 3.717214584350586 | 3.8401012420654297 | 2.800438642501831 | -1 |
Net dept to EBITDA | -1.7281463146209717 | -1.4859418869018555 | -1.5093004703521729 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane